Company: LRHC
Filing Date: 2025-06-27
Form Type: S-1/A
Source: 0001213900-25-058528
Chunk: 31

Company: La Rosa Holdings Corp.
Filing Date: 2025-06-27
Form: S-1/A
Chunk 31
---
The Company has not declared nor paid any cash dividends on its publicly traded common stock after the completion of our IPO in October 2023. We currently intend to retain earnings and profits, if any, to support our business strategy and do not intend to pay any cash dividends within the foreseeable future. Any future determination to pay cash dividends will be at the sole discretion of our Board of Directors and will depend upon the financial condition of the Company, its operating results, capital requirements, general business conditions and any other factors that our Board of Directors deems relevant.

<div align='center'>16

PRIVATE PLACEMENT</div>

Securities Purchase Agreement and Exchange Agreement

As we reported in a Current Report on Form
8-K filed with the SEC on February 5, 2025, on February 4, 2025 (the “Closing Date”) we entered into a securities purchase
agreement (the “SPA”) with the Selling Stockholder pursuant to which we agreed to issue and sell to the Selling Stockholder,
upon the terms and conditions set forth in the SPA: (i) a Senior Secured Convertible Note in the original principal amount of $5,500,000
which matures on the two-year anniversary of the Closing Date (the “Initial Note”); and (ii) sixteen (16) warrants (“Incremental
Warrants”), each to purchase additional Notes in an original principal amount up to $2,500,000 at an exercise price of $2,256,250,
in substantially the same form as the Initial Note (“Incremental Notes” and together with the Initial Note, the “Notes”).
The Incremental Warrants and Initial Note were issued to the Seller Stockholder on the Closing Date. The purchase price paid by the Selling
Stockholder under the SPA for the Initial Note and Incremental Warrants is $4,963,750, which has been or may be used by the Company to
pay-off certain indebtedness, pay certain outstanding fees and expenses, acquisitions and general corporate purposes. The Company also
granted the Selling Stockholder registration rights in the shares of common stock offered hereby under the Registration Rights Agreement
(as defined below).

Pursuant to the terms of the SPA, the Company
is required, as promptly as practicable but prior to the sixtieth (60th) calendar day after the Closing Date, to obtain the prior written
consent of the requisite stockholders (the “Stockholder Consent”) to obtain the Stockholder Approval (as defined below) and